New! View global litigation for patent families

US20120125527A1 - Heterogeneous Yarns For Surgical Articles - Google Patents

Heterogeneous Yarns For Surgical Articles Download PDF

Info

Publication number
US20120125527A1
US20120125527A1 US13362502 US201213362502A US2012125527A1 US 20120125527 A1 US20120125527 A1 US 20120125527A1 US 13362502 US13362502 US 13362502 US 201213362502 A US201213362502 A US 201213362502A US 2012125527 A1 US2012125527 A1 US 2012125527A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
strands
yarn
heterogeneous
plurality
yarns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13362502
Inventor
John J. Kennedy
Joshua Stopek
Mark S. Roby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Covidien LP
Original Assignee
Covidien LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L31/125Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L31/129Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing macromolecular fillers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L17/00Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06At least partially resorbable materials
    • A61L17/10At least partially resorbable materials containing macromolecular materials
    • A61L17/105Polyesters not covered by A61L17/12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L31/125Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • DTEXTILES; PAPER
    • D02YARNS; MECHANICAL FINISHING OF YARNS OR ROPES; WARPING OR BEAMING
    • D02GCRIMPING OR CURLING FIBRES, FILAMENTS, THREADS, OR YARNS; YARNS OR THREADS
    • D02G3/00Yarns or threads, e.g. fancy yarns; Processes or apparatus for the production thereof, not otherwise provided for
    • D02G3/44Yarns or threads characterised by the purpose for which they are designed
    • D02G3/448Yarns or threads for use in medical applications
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04CBRAIDING OR MANUFACTURE OF LACE, INCLUDING BOBBIN-NET OR CARBONISED LACE; BRAIDING MACHINES; BRAID; LACE
    • D04C1/00Braid or lace, e.g. pillow-lace; Processes for the manufacture thereof
    • D04C1/02Braid or lace, e.g. pillow-lace; Processes for the manufacture thereof made from particular materials
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04CBRAIDING OR MANUFACTURE OF LACE, INCLUDING BOBBIN-NET OR CARBONISED LACE; BRAIDING MACHINES; BRAID; LACE
    • D04C1/00Braid or lace, e.g. pillow-lace; Processes for the manufacture thereof
    • D04C1/06Braid or lace serving particular purposes
    • D04C1/12Cords, lines, or tows
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00Applications
    • C08L2203/12Applications used for fibers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/04Homopolymers or copolymers of ethene
    • C08L23/06Polyethene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2321/00Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D10B2321/02Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds polyolefins
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2331/00Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products
    • D10B2331/04Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyesters, e.g. polyethylene terephthalate [PET]
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2403/00Details of fabric structure established in the fabric forming process
    • D10B2403/03Shape features
    • D10B2403/031Narrow fabric of constant width
    • D10B2403/0311Small thickness fabric, e.g. ribbons, tapes or straps
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2509/00Medical; Hygiene
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2509/00Medical; Hygiene
    • D10B2509/04Sutures

Abstract

Heterogeneous yarns containing strands of dissimilar materials are useful in forming surgical device.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • [0001]
    The present application is a divisional of, and claims the benefit of and priority to, co-pending U.S. patent application Ser. No. 12/504,954 filed on Jul. 17, 2009, which is a continuation-in-part of, and claims the benefit of and priority to, U.S. patent application Ser. No. 10/917,183 filed on Aug. 12, 2004, now abandoned, which claims priority to and the benefit of U.S. Provisional Application No. 60/494,993 filed on Aug. 14, 2003, the entire disclosures of each of which are hereby incorporated by reference in their entirety.
  • BACKGROUND
  • [0002]
    1. Technical Field
  • [0003]
    The present disclosure relates to yarns made of dissimilar materials. Filaments of at least two dissimilar materials are combined to form a yarn which, in turn, can be braided, woven, etc. to form a device suitable for surgical use.
  • [0004]
    2. Background of Related Art
  • [0005]
    Sutures intended for the repair of body tissues must meet certain requirements; they must be substantially non-toxic, capable of being readily sterilized, they must have good tensile strength and have acceptable knot-tying and knot-holding characteristics and, if the sutures are of the bio-absorbable variety, the bio-absorption of the suture must be closely controlled.
  • [0006]
    Sutures have been constructed from a wide variety of materials including surgical gut, silk, cotton, polyolefins such as polypropylene, polyamides, polyesters such as polyethylene terephthalate, polyglycolic acid, glycolide-lactide copolymer, etc. Sutures have been constructed from these materials in a monofilament form and as braided structures. For example, sutures manufactured from silk, polyamide, polyester and bio-absorbable glycolide-lactide copolymer are typically provided as multi-filament braids.
  • [0007]
    Filaments have also been utilized to form other mutli-filament surgical or medical devices, such as braided tapes, gauze, wound dressings, hernial repair meshes, vascular grafts (e.g. fabrics and/or tubes) anastomosis rings, prosthetic ligaments and tendons, growth matrices, drug delivery devices and other implantable medical devices. Multi-filaments braids typically provide the advantages of enhanced pliability, and tensile strength as compared to monofilament constructions, and where utilized as sutures, posses enhanced knot security. The enhanced pliability of a multi-filament braid is caused by a lower resistance to bending of a strand of very fine filaments as opposed to one large diameter monofilament. The individual filaments must be able to bend unencumbered or unrestricted by their neighboring filaments. Any mechanism which reduces this individual fiber mobility, such as simple fiber-fiber friction, a coating which penetrates into the braid interstices, or a melted polymer matrix which adheres fibers together, could adversely affect braid pliability. It would be advantageous to combine dissimilar materials or fibers to form filament strands to enhance pliability and strength.
  • SUMMARY
  • [0008]
    The present disclosure relates to biocompatible composite surgical devices made from heterogeneous yarns. The yarns contain multiple strands of a polyester material and multiple strands of a polyolefin material. The strands are combined in substantially parallel lengths with respect to each other to form the heterogeneous yarn. The yarns can then be braided, knitted or woven to form medical/surgical devices, including sutures.
  • BRIEF DESCRIPTION OF DRAWINGS
  • [0009]
    FIG. 1 is a cross sectional view of a heterogeneous yarn of polyester and polyolefin strands;
  • [0010]
    FIG. 2 shows a needle-suture combination in accordance with the present disclosure;
  • [0011]
    FIG. 3 is a perspective view of a portion of a split human sternum illustrating one application of the present invention for retaining the split portions together to promote healing;
  • [0012]
    FIG. 4 is an enlarged view of the suture product shown in FIG. 3 illustrating one embodiment wherein the elongated product is a flat braided member and contains at least eight reinforcing filaments extending along the length;
  • [0013]
    FIG. 5 is a view of an alternative embodiment of the suture repair product wherein the elongated member is a spiroid braided member having a generally circular cross-section containing at least one elongated reinforcing member; and
  • [0014]
    FIG. 6 is a view of another alternative embodiment of the suture repair product wherein the elongated product is a hollow braided member having a generally circular cross-section and contains at least one elongated reinforcing member extending centrally thereof along the length.
  • DETAILED DESCRIPTION
  • [0015]
    The present disclosure relates to heterogeneous yarns, which can be used in the fabrication in whole or in part of a variety of textile surgical devices, including, for example, sutures, braided tapes, gauze, wound dressings, hernial repair meshes, vascular grafts (e.g. fabrics and/or tubes) anastomosis rings, prosthetic ligaments and tendons, growth matrices, drug delivery devices and other implantable medical devices. An implantable medical device is defined as any device which can be implanted in an animal for medical purposes. The yarns can be braided, knitted or woven to form the devices.
  • [0016]
    In accordance with the present disclosure, at least two different kinds of fibers or strands are placed in intimate contact to form a heterogeneous yarn. More particularly, the heterogeneous yarns contain strands made from a polyester and strands made from a polyolefin. Multiple strands of polyester and polyolefin are combined to form a single yarn. Multiple heterogeneous yarns thus obtained are then braided, knitted, or woven to form a multi-filament surgical/medical device, such as, for example, a multi-filament surgical suture.
  • [0017]
    In particularly useful embodiments, the polyester strands are made of polyethylene terephthalate. Polyethylene terephthalate is a thermoplastic polyester formed by esterification from ethylene glycol and terephthalic acid. Its advantageous properties include high tensile strength, high resistance to stretching under both wet and dry conditions, and good resistance to degradation by chemical bleaches and to abrasion. Polyethylene terephthalate is commercially available from DuPont Corporation, Wilmington, Del., under the trademark DACRON®.
  • [0018]
    The polyolefin strands are preferably made from a polyethylene. In particularly useful embodiments, the polyethylene is an ultra high molecular weight polyethylene. Ultra high molecular weight (“UHMW”) polyethylene is a linear polymer with an average molecular weight greater than about 400,000, typically in the range of about 500,000 to about 6,000,000. UHMW polyethylene has a high tenacity and low elongation rate to provide articles with greatly increased strength and decreased elongation.
  • [0019]
    UHMW polyethylene typically exhibits a very substantial degree of crystalline orientation (95-99%) and crystalline content (60-85%). The significant strength and stability of UHMW polyethylene is normally caused by the high degree of molecular orientation. As a result, the fibers exhibit strengths from about 375 kpsi (thousands of pounds per square inch) to about 560 kpsi, and tensile moduli of about 15 msi (millions of pounds per square inch) to about 30 msi. Ultra high molecular weight polyethylene is commercially available under the trademark SPECTRA®. from Allied-Signal Technologies, Petersburg, Va., and under the trademark DYNEEMA® from DSM High Performance Fibers, JH Heerlen, The Netherlands.
  • [0020]
    The yarn may optionally contain strands of other materials. Materials used to construct these optional strands can include a wide variety of natural and synthetic fibrous materials such as any of those previously known for the construction of sutures. Such materials include non-absorbable as well as partially and fully bio-absorbable (i.e., resorbable) natural and synthetic fiber-forming polymers, including thermoplastics. Suitable non-absorbable materials can include, for example, polyamides, polyesters such as polyethylene terephthalate, polyacrylonitrile, polyolefins such as polyethylene and polypropylene, silk, cotton, linen, etc. Carbon fibers, steel fibers and other biologically acceptable inorganic fibrous materials can also be employed. Bio-absorbable resins can include those derived from glycolic acid, glycolide, lactic acid, lactide, dioxanone, epsilon-caprolactone, trimethylene carbonate, etc., and various combinations of these and related monomers.
  • [0021]
    The strands which form the yarns can be made using any known technique, such as, for example, extrusion, molding and/or solvent casting. In a preferred embodiment, the strands can be extruded through an extruder unit of a conventional type, such as those disclosed in U.S. Pat. Nos. 6,063,105; 6,203,564; and 6,235,869, the contents of each of which are incorporated by reference herein. The strands of dissimilar materials can be extruded separately and subsequently brought together into a group to form a yarn, or the strands can be extruded in a side-by-side fashion and collected together to immediately form a yarn. The number of strands used per yarn will depend on a number of factors including the desired final size of the yarn and the ultimate multi-filament article being produced. For example, with respect to sutures, size is established according to United States Pharmacopoceia (“USP”) standards. However, each yarn can contain at least ten strands, and often more, of at least two differing material types. The strands run parallel to each other along the length of the yarn. Although twisting the strands to form a twisted yarn is also contemplated.
  • [0022]
    Turning now to FIG. 1, heterogeneous yarn 10 of the present disclosure is shown. Yarn 10 may be formed, in embodiments extruded, to any suitable length. More particularly, the extruded length of the yarn 10 may be determined by the intent of use of the yarn 10. For example, in the instance where the intended use of the yarn 10 is for the manufacture of a suture 101, the yarn 10 includes a length that is at least equal to the length of the suture (see FIG, 2, for example). In embodiments, yarn 10 may include lengths that are from about 5 inches to about 144 inches. For illustrative purposes, a segment of a yarn 10 is depicted in FIG. 1 and includes a plurality of polyolefin strands 12 (such as, UHMW polyethylene) and polyester strands 14 (such as DACRON®). While only a segment of yarn 10 is depicted in FIG. 1, it is to be understood that, in embodiments, the parallel orientation of strands 12 and 14 may be maintained along the entire length of yarn 10 (not shown). In other words, the plurality of strands 12 and 14 run parallel to both each other and the longitudinal axis of yarn 10, along the length of yarn 10.
  • [0023]
    As noted above, yarn 10 may be formed by one or more known extrusion processes. After the strands 12 and 14 have been extruded and subsequently brought together and/or collected, each of the strands 12 and 14 are arranged and maintained so that they are in intimate contact with each other in a parallel relation relative to one another. This parallel configuration of strands 12 and 14 may increase the structural integrity of the yarn 10.
  • [0024]
    The strands 12 and 14 may be maintained in this parallel relation by any suitable methods and/or processes. For example, in an embodiment, the strands 12 and 14 may be temporarily positioned within a holding receptacle, such as, for example, a removable forming sheath (not shown). The forming sheath may be configured to maintain the strands 12 and 14 in a parallel configuration during the formation of the yarn 10.
  • [0025]
    In embodiments, after the strands 12 and 14 have been positioned within the forming sheath, the strands 12 and 14 may be subsequently bonded to each other by any means within the purview of those skilled in the art. Such means may include, for example, the application of heat, the use of binding agents, the use of coatings, combinations thereof, and the like. In embodiments, instead of a forming sheath, a permanent sheath may be applied to the external surface of yarn 10, thereby assisting in maintaining the parallel orientation of strands 12 and 14.
  • [0026]
    A sheath which is applied to the strands 12 and 14 and left thereon to maintain their parallel orientation may be formed of any materials used to form strands 12 and/or 14, as well as any other component utilized to form a suture of the present disclosure.
  • [0027]
    Depending upon the materials utilized to form the strands, in embodiments, suitable heating to fuse the strands together may include heating to from about 70° C. to about 160° C., in embodiments from about 100° C. to about 140° C.
  • [0028]
    The heating may be dependent upon the glass transition temperature of the materials utilized to form the strands. Moreover, in embodiments, it may be desirable to heat the strands under tension, to maintain the parallel orientation of the strands.
  • [0029]
    Suitable binding agents are within the purview of those skilled in the art and include suitable biocompatible adhesives, thermoplastic resins, waxes, combinations thereof, and the like. In embodiments, a plurality of interstices “I” may be formed between the plurality of strands 12 and 14. The interstices “I” run parallel to each other and the strands 12 and 14 along the length of the yarn 10. In embodiments, the plurality of interstices may be configured to provide an area for receiving the binding agent “A”. The binding agent “A” may be applied along the entire length of the yarn, or in discrete locations along the length of the yarn. In embodiments it may prove useful to apply the binding agent may be deposited at specific locations or nodes “n” along the length of the yarn, see FIG. 1. The plurality of nodes “n” and/or forming sheath may be configured to receive the binding agent at corresponding predetermined locations along the length of the yarn 10. The plurality of nodes “n” may be configured to maintain the strands 12 and 14 in a fixed parallel relation relative to one another.
  • [0030]
    Thus, in embodiments, a method for forming a yarn of the present disclosure may include positioning a plurality of strands in side-by-side fashion such that the plurality of strands are maintained in a parallel relation relative to one another, applying a binding agent to the plurality of heterogeneous strands, and setting the binding agent to assist in maintaining the strands in their parallel configuration.
  • [0031]
    Any biocompatible adhesive may be utilized. In embodiments, suitable adhesive materials include synthetic absorbable and non-absorbable monomers and oligomers including those synthesized from materials such as lactic acid, glycolic acid, caprolactone, dioxanone, polyethylene glycol (PEG), polypropylene glycol, isocyanates, copolymers thereof, combinations thereof, and the like. Adhesive materials may be combined with solvents for their application, including polar and non-polar solvents. Suitable solvents include alcohols, e.g., methanol, ethanol, propanol, chlorinated hydrocarbons (such as methylene chloride, chloroform, 1,2-dichloro-ethane), and aliphatic hydrocarbons such as hexane, heptene, ethyl acetate.
  • [0032]
    The specific manner in which the binding agent may be applied to the yarn 10 will depend on the contemplated uses of the suture. After the binding agent is applied to the strands 12 and 14, strands 12 and 14 and/or the binding agent may be set using known curing methods or processes (e.g., ultra-violet curing) or other suitable methods or processes not described herein.
  • [0033]
    In embodiments, the strands 12 and 14 and/or the binding agent may be simultaneously subjected to an ultra-violet curing process. Following the ultra-violet curing process, the forming sheath may be subsequently removed, producing a yarn 10 that includes the strands 12 and 14 in a fixed parallel configuration.
  • [0034]
    In embodiments, after the strands 12 and 14 have been set or formed in the fixed parallel configuration, the yarn 10 including the strands 12 and 14 may be treated with a suitable coating (not shown). In embodiments, the coating may be employed to facilitate in maintaining the strands 12 and 14 in a parallel configuration. Any biocompatible coating may be applied thereto, including those disclosed in U.S. Patent Application Publication Nos. 2008/0268243, 2007/0207189, 2007/0010856, 2006/0188545, 2004/0153125, and 2004/0147629, and U.S. Pat. Nos. 6,878,757, 6,136,018, 6,007,565, and 5,716,376, the entire disclosures of each of which are incorporated by reference herein.
  • [0035]
    A coating and/or sheath may be applied in discrete locations or, in embodiments, may be applied along the longitudinal distance of the suture. Where applied in discrete locations, the locations may be intermittent and/or discrete, or may be along one or more partial lengths of continuous and/or increasing and/or decreasing change in length along the suture.
  • [0036]
    Once formed, a plurality of the heterogeneous yarns 10 can then be braided, knitted, or woven together. The braiding can be done by any method known to those skilled in the art. For example, braid constructions for sutures and other medical devices are described in U.S. Pat. Nos. 5,019,093; 5,059,213; 5,133,738; 5,181,923; 5,226,912; 5,261,886; 5,306,289; 5,318,575; 5,370,031; 5,383,387; 5,662,682; 5,667,528; 6,203,564; the contents of each of which are incorporated by reference herein. Once the suture is constructed, it is preferably sterilized, by any means known to those skilled in the art.
  • [0037]
    Braided surgical devices made using heterogeneous yarns prepared in accordance with the disclosure can optionally be coated with one or more coating compositions to improve functional properties of the device. For example, a coating can be applied to improve surface lubricity and knot tie-down behavior. Suitable coating compositions include but are not limited to those disclosed in U.S. Pat. Nos. 3,867,190; 3,942,532; 4,047,533; 4,452,973; 4,624,256; 4,649,920; 4,716,203; 4,826,945; and 5,569,302, the disclosures of which are incorporated by reference herein. The coating can be applied using any known technique such as, for example coating, dipping, spraying or other appropriate techniques.
  • [0038]
    The amount of coating composition applied to the device will vary depending upon the specific construction of the device, its size and the exact material of its construction. In general, the coating composition will constitute from about 0.5 to about 4.0 percent by weight of the coated device or higher with a preferred range from about 1.0 percent to about 3.0 percent.
  • [0039]
    A surgical device prepared from the presently described heterogeneous yarns may also be impregnated with one or more medico-surgically useful substances, e.g., those which accelerate or beneficially modify the healing process when the suture is applied to a wound or surgical site. The medically useful or therapeutic agents can include varying amounts of one or more optional ingredients, such as, for example, bioactive substances such as biocidal agents, antibiotics, antimicrobials, medicants, growth factors, anti-clotting agents, analgesic, anesthetics, anti-inflammatory, etc., and the like. Medicants are defined as substances which are beneficial to the animal and tend to promote the healing process. For example, a braided suture can be provided with a therapeutic agent which will be deposited at the sutured site. The therapeutic agent can be chosen for its antimicrobial properties, capability for promoting wound repair and/or tissue growth, or for specific indications such as thrombosis. Antimicrobial agents such as broad spectrum antibiotics (gentamicin sulphate, erythromycin or derivatized glycopeptides) which are slowly released into the tissue can be applied in this manner to aid in combating clinical and sub-clinical infections in a surgical or trauma wound site. To promote wound repair and/or tissue growth, one or more biologically active materials known to achieve either or both of these objectives can also be applied to the braided suture. Such materials include any of several human Growth factors (HGFs), magainin, tissue or kidney plasminogen activator to cause thrombosis, superoxide dismutase to scavenge tissue-damaging free radicals, tumor necrosis factor for cancer therapy, colony stimulating factor, interferon, interleukin-2 or other lymphokines to enhance the immune system, and so forth.
  • [0040]
    The braided device prepared from heterogeneous yarns in accordance with this disclosure can also include, for example, biologically acceptable plasticizers, antioxidants, and colorants, which can be impregnated into the heterogeneous yarns of the device.
  • [0041]
    In addition, the yarn and/or product may be plasma treated depending upon the particular needs or intended application so as to reduce the perceived “slipperiness” of the product as desired.
  • [0042]
    The braided suture 101 prepared in accordance with this disclosure can have a needle 102 attached thereto as shown in FIG. 2, to provide a needle suture combination 100. In order to facilitate needle attachment, conventional tipping agents can be applied to the braid. Two tipped ends of the suture may be desirable for attaching a needle to each end of the suture to provide a so-called double armed suture. The needle attachment can be made by any conventional method such as crimping, swaging, etc., including those described in U.S. Pat. Nos. 5,133,738; 5,226,912; and 5,569,302, the disclosures of which are incorporated by reference herein.
  • [0043]
    As noted above the heterogeneous yarns of the present disclosure can also be utilized to form other surgical or medical articles, including, braided tapes, gauze, wound dressings, hernial repair meshes, vascular grafts (e.g. fabrics and/or tubes) anastomosis rings, prosthetic ligaments and tendons, growth matrices, drug delivery devices and other implantable medical devices.
  • [0044]
    Referring initially to FIG. 3 there is illustrated a sternum closure ribbon 110 constructed according to the present invention and positioned to retain portions 112, 114 of a human sternum 116 together. The band 110 is a braided product made from the heterogeneous yarns described herein. In FIG. 4, the band 110 shown in FIG. 3 is shown in greater detail as an elongated flat braided textile product prepared as described in U.S. Pat. No. 5,318,575, the disclosure of which is incorporated herein by reference, with the exception that heterogeneous yarns in accordance with the present disclosure are used in the construction.
  • [0045]
    Accordingly, it is possible in one application to position the reinforced structure 110 about the split portions 112, 114 of the human sternum 116 as shown in FIG. 3 whereby substantial force may be applied to the band by tying the band either by a knot 122 shown in FIG. 3, or by other techniques whereby significant force may be applied and retained to promote natural healing of the sternum portions 112, 114, e.g. mechanical connecting devices such as buckles, etc. See, for example, U.S. Pat. No. 4,813,416.
  • [0046]
    In FIG. 5, there is an alternative elongated embodiment of spiroid braided construction of generally circular cross-section and comprised of heterogeneous yarns 126 combined to form a braided rope-like construction of generally circular cross-sectional configuration. Braid constructions having a circular cross-section are described in U.S. Pat. Nos. 3,565,077 and 5,019,093. In FIG. 6 there is shown a hollow braid construction 128 having a sheath constructed of heterogeneous yarns 130 and having a core 132.
  • [0047]
    Surgical devices prepared from heterogeneous yarns in accordance with this disclosure can be packaged and sterilized in any conventional manner known to those skilled in the art.
  • [0048]
    It will be understood that various modifications may be made to the embodiments disclosed herein. For example, in any of the braided products described herein one or more of the yarns may be heterogeneous yarns in accordance with this disclosure while the remaining portions are made of absorbable or non-absorbable fibers or filaments. As one illustrative example, for braided products containing a core/sheath structure, the core may be a heterogeneous yarns in accordance with this disclosure while the sheath yarns can be made form other biocompatible fibers, including, but not necessarily, bioabsorbable fibers. Therefore the above description should not be construed as limiting, but merely as exemplications of preferred embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.

Claims (18)

  1. 1. A method of manufacturing a yarn for use with a surgical device comprising:
    positioning a plurality of heterogeneous strands in side-by-side fashion such that the plurality of heterogeneous strands are maintained in a parallel relation to one another;
    applying a binding agent to the plurality of heterogeneous strands; and
    setting the binding agent.
  2. 2. A method according to claim 1, further comprising forming the heterogeneous strands via an extrusion process.
  3. 3. A method according to claim 2, wherein the plurality of heterogeneous strands are extruded to a length from about 5 inches to about 144 inches.
  4. 4. A method according to claim 1, wherein positioning the plurality of heterogeneous strands occurs within a holding receptacle configured to maintain the plurality of heterogeneous strands in the parallel relation to one another.
  5. 5. A method according to claim 4, wherein the holding receptacle is a forming sheath.
  6. 6. A method according to claim 4, wherein the holding receptacle is a permanent sheath that is applied to a surface of the plurality of heterogeneous strands.
  7. 7. A method according to claim 4, wherein the holding receptacle is made from the same material as the plurality of heterogeneous strands.
  8. 8. A method according to claim 1, wherein setting the binding agent occurs by heating the binding agent.
  9. 9. A method according to claim 8, wherein heating the binding agent occurs at a temperature from about 70° C. to about 160° C.
  10. 10. A method according to claim 8, wherein heating the binding agent occurs at a temperature from about 100° C. to about 140° C.
  11. 11. A method according to claim 8, wherein heating the binding agent further comprises tensioning the plurality of heterogeneous strands to facilitate maintaining the parallel relation of the plurality of heterogeneous strands with respect to one another.
  12. 12. A method according to claim 1, wherein the binding agent is applied along the entire length of the plurality of heterogeneous strands.
  13. 13. A method according to claim 1, wherein the binding agent is applied along discrete locations along the length of the plurality of heterogeneous strands.
  14. 14. A method according to claim 1, wherein the binding agent is selected from the group consisting of biocompatible adhesives, thermoplastic resins, waxes, and combinations thereof.
  15. 15. A method according to claim 14, wherein the biocompatible adhesives are selected from the group consisting of synthetic absorbable and non-absorbable monomers and oligomers.
  16. 16. A method according to claim 15, wherein the synthetic absorbable and non-absorbable monomers and oligomers are selected from the group consisting of lactic acid, glycolic acid, caprolactone, dioxanone, polyethylene glycol (PEG), polypropylene glycol, isocyanates, copolymers thereof, and combinations thereof.
  17. 17. A method according to claim 1, wherein positioning the plurality of heterogeneous strands in side-by-side fashion forms a corresponding plurality of interstices between the plurality of heterogeneous strands.
  18. 18. A method according to claim 17, wherein the plurality of interstices are configured to provide an area for receiving the binding agent therein.
US13362502 2003-08-14 2012-01-31 Heterogeneous Yarns For Surgical Articles Abandoned US20120125527A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US49499303 true 2003-08-14 2003-08-14
US10917183 US20050125036A1 (en) 2003-08-14 2004-08-12 Heterogeneous yarns for surgical articles
US12504954 US20100016891A1 (en) 2003-08-14 2009-07-17 Heterogeneous yarns for surgical articles
US13362502 US20120125527A1 (en) 2003-08-14 2012-01-31 Heterogeneous Yarns For Surgical Articles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13362502 US20120125527A1 (en) 2003-08-14 2012-01-31 Heterogeneous Yarns For Surgical Articles

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12504954 Division US20100016891A1 (en) 2003-08-14 2009-07-17 Heterogeneous yarns for surgical articles

Publications (1)

Publication Number Publication Date
US20120125527A1 true true US20120125527A1 (en) 2012-05-24

Family

ID=43126904

Family Applications (2)

Application Number Title Priority Date Filing Date
US12504954 Abandoned US20100016891A1 (en) 2003-08-14 2009-07-17 Heterogeneous yarns for surgical articles
US13362502 Abandoned US20120125527A1 (en) 2003-08-14 2012-01-31 Heterogeneous Yarns For Surgical Articles

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12504954 Abandoned US20100016891A1 (en) 2003-08-14 2009-07-17 Heterogeneous yarns for surgical articles

Country Status (4)

Country Link
US (2) US20100016891A1 (en)
EP (1) EP2275149A3 (en)
JP (1) JP2011019903A (en)
CA (1) CA2708998A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110238169A1 (en) * 2010-03-23 2011-09-29 Boston Scientific Scimed, Inc. Annuloplasty device
WO2017019300A1 (en) * 2015-07-27 2017-02-02 Drexel University Heterogeneous filaments, methods of producing the same, scaffolds, methods of producing the same, droplets, and methods of producing the same

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8348973B2 (en) * 2006-09-06 2013-01-08 Covidien Lp Bioactive substance in a barbed suture
EP1897500B1 (en) * 2006-09-06 2009-07-29 Tyco Healthcare Group, LP Barbed sutures
US8515556B2 (en) 2010-10-29 2013-08-20 Medtronic, Inc. Reinforced silicone insulation for implantable medical electrical leads
US9080263B2 (en) 2012-02-10 2015-07-14 Novus Scientific Ab Multifilaments with time-dependent characteristics, and medical products made from such multifilaments

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883486A (en) * 1988-05-31 1989-11-28 Indu Kapadia Prosthetic ligament
US5674286A (en) * 1991-02-12 1997-10-07 United States Surgical Corporation Bioabsorbable medical implants

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565077A (en) 1968-05-06 1971-02-23 American Cyanamid Co Densified absorbably polyglycolic acid suture braid, and method for preparing same
US3867190A (en) 1971-10-18 1975-02-18 American Cyanamid Co Reducing capillarity of polyglycolic acid sutures
BE806869A (en) 1972-11-03 1974-04-30 Ethicon Inc Wire ligatures braid improves
US4014973A (en) * 1973-07-31 1977-03-29 Ethicon, Inc. Method of compacting silk sutures by stretching
US4047533A (en) 1976-09-20 1977-09-13 American Cyanamid Company Absorbable surgical sutures coated with polyoxyethylene-polyoxypropylene copolymer lubricant
US4452973A (en) 1982-11-12 1984-06-05 American Cyanamid Company Poly(glycolic acid)/poly(oxyethylene) triblock copolymers and method of manufacturing the same
JPS614546B2 (en) * 1983-06-07 1986-02-10 Toray Industries
US4624256A (en) 1985-09-11 1986-11-25 Pfizer Hospital Products Group, Inc. Caprolactone polymers for suture coating
US4649920A (en) 1986-01-30 1987-03-17 Pfizer Hospital Products Group, Inc. Coated suture
US4759765A (en) * 1986-03-17 1988-07-26 Minnesota Mining And Manufacturing Company Tissue augmentation device
US4716203A (en) 1986-09-05 1987-12-29 American Cyanamid Company Diblock and triblock copolymers
US4813416A (en) 1987-03-18 1989-03-21 The Research Foundation Of State University Of New York Bonding assembly and method for sternum closing
US4826945A (en) 1987-06-09 1989-05-02 Yissum Research Development Company Biodegradable polymeric materials based on polyether glycols, processes for the preparation thereof and surgical articles made therefrom
US5261886A (en) 1987-08-26 1993-11-16 United States Surgical Corporation Cabled core and braided suture made therefrom
US5226912A (en) 1987-08-26 1993-07-13 United States Surgical Corporation Combined surgical needle-braided suture device
US5306289A (en) * 1987-08-26 1994-04-26 United States Surgical Corporation Braided suture of improved characteristics
US5019093A (en) * 1989-04-28 1991-05-28 United States Surgical Corporation Braided suture
US4977739A (en) * 1989-06-26 1990-12-18 Du Pont Canada Inc. Method and apparatus for making composite yarn
US5133738A (en) 1989-09-27 1992-07-28 United States Surgical Corporation Combined surgical needle-spiroid braided suture device
US5059213A (en) * 1990-03-26 1991-10-22 United States Surgical Corporation Spiroid braided suture
US5181923A (en) 1990-03-26 1993-01-26 United States Surgical Corporation Spiroid braided suture
US5370031A (en) 1990-08-17 1994-12-06 United States Surgical Corporation Braider apparatus with improved bobbin holder
CA2048464A1 (en) 1990-08-17 1992-02-18 Michael P. Chesterfield Apparatus and method for producing braided suture products
CA2704193C (en) * 1990-12-13 2011-06-07 United States Surgical Corporation Method and apparatus for tipping sutures
US5318575A (en) * 1992-02-03 1994-06-07 United States Surgical Corporation Method of using a surgical repair suture product
US5314446A (en) * 1992-02-19 1994-05-24 Ethicon, Inc. Sterilized heterogeneous braids
US5366504A (en) * 1992-05-20 1994-11-22 Boston Scientific Corporation Tubular medical prosthesis
US5284489A (en) * 1992-08-19 1994-02-08 United States Surgical Corporation Filament fabricated from a blend of ionomer resin and nonionic thermoplastic resin
US5667528A (en) * 1995-11-22 1997-09-16 United States Surgical Corporation Braided suture surgical incision member attachment
US6063105A (en) 1996-06-18 2000-05-16 United States Surgical Medical devices fabricated from elastomeric alpha-olefins
US5716376A (en) 1996-06-28 1998-02-10 United States Surgical Corporation Absorbable mixture and coatings for surgical articles fabricated therefrom
US6007565A (en) 1997-09-05 1999-12-28 United States Surgical Absorbable block copolymers and surgical articles fabricated therefrom
US6203564B1 (en) * 1998-02-26 2001-03-20 United States Surgical Braided polyester suture and implantable medical device
US6235869B1 (en) 1998-10-20 2001-05-22 United States Surgical Corporation Absorbable polymers and surgical articles fabricated therefrom
US6045571A (en) * 1999-04-14 2000-04-04 Ethicon, Inc. Multifilament surgical cord
US6601378B1 (en) * 1999-09-08 2003-08-05 Honeywell International Inc. Hybrid cabled cord and a method to make it
US6716234B2 (en) * 2001-09-13 2004-04-06 Arthrex, Inc. High strength suture material
US6878757B2 (en) 2002-12-11 2005-04-12 Tyco Healthcare Group Lp Antimicrobial suture coating
WO2004054503A3 (en) 2002-12-13 2004-10-14 Tyco Healthcare Antimicrobial fatty acid containing suture coating
WO2004066927A3 (en) 2003-01-24 2004-11-04 Tyco Healthcare Bioabsorbable composition and coatings including same
US20050125036A1 (en) * 2003-08-14 2005-06-09 Mark Roby Heterogeneous yarns for surgical articles
US7134267B1 (en) * 2003-12-16 2006-11-14 Samson Rope Technologies Wrapped yarns for use in ropes having predetermined surface characteristics
US7329271B2 (en) * 2003-12-18 2008-02-12 Ethicon, Inc. High strength suture with absorbable core
JP2007021189A (en) 2005-07-11 2007-02-01 Tyco Healthcare Group Lp Antibacterial suture and method for manufacturing the same
EP1993520A4 (en) 2006-02-28 2012-10-31 Tyco Healthcare Antimicrobial medical devices
US8309222B2 (en) 2007-04-25 2012-11-13 Covidien Lp Coated filaments
US8709562B2 (en) * 2007-08-21 2014-04-29 Honeywell International, Inc. Hybrid fiber constructions to mitigate creep in composites

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883486A (en) * 1988-05-31 1989-11-28 Indu Kapadia Prosthetic ligament
US5674286A (en) * 1991-02-12 1997-10-07 United States Surgical Corporation Bioabsorbable medical implants

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110238169A1 (en) * 2010-03-23 2011-09-29 Boston Scientific Scimed, Inc. Annuloplasty device
US8556966B2 (en) * 2010-03-23 2013-10-15 Boston Scientific Scimed, Inc. Annuloplasty device
WO2017019300A1 (en) * 2015-07-27 2017-02-02 Drexel University Heterogeneous filaments, methods of producing the same, scaffolds, methods of producing the same, droplets, and methods of producing the same

Also Published As

Publication number Publication date Type
JP2011019903A (en) 2011-02-03 application
US20100016891A1 (en) 2010-01-21 application
EP2275149A3 (en) 2013-04-10 application
EP2275149A2 (en) 2011-01-19 application
CA2708998A1 (en) 2011-01-17 application

Similar Documents

Publication Publication Date Title
US3297033A (en) Surgical sutures
US3422181A (en) Method for heat setting of stretch oriented polyglycolic acid filament
US3463158A (en) Polyglycolic acid prosthetic devices
US6235869B1 (en) Absorbable polymers and surgical articles fabricated therefrom
US6206908B1 (en) Absorbable polymer and surgical articles fabricated therefrom
US6162537A (en) Implantable fibers and medical articles
US5534288A (en) Infection-resistant surgical devices and methods of making them
US5951997A (en) Aliphatic polyesters of ε-caprolactone, p-dioxanone and gycolide
US5147382A (en) Elastomeric surgical sutures comprising segmented copolyether/esters
US20060058470A1 (en) Non-curling polyhydroxyalkanoate sutures
US20070134292A1 (en) Synthetic, bioabsorbable polymer materials and implants
US5700287A (en) Prosthetic vascular graft with deflectably secured fibers
US6494898B1 (en) Absorbable copolymers and surgical articles fabricated therefrom
US5376118A (en) Support material for cell impregnation
US6045571A (en) Multifilament surgical cord
US20040234576A1 (en) Polyhydroxyalkanoate medical textiles and fibers
US5318575A (en) Method of using a surgical repair suture product
US4915893A (en) Method of preparing polyester filament material
US5423859A (en) Jet entangled suture yarn and method for making same
US4052988A (en) Synthetic absorbable surgical devices of poly-dioxanone
US5431679A (en) Absorbable block copolymers and surgical articles fabricated therefrom
US6063105A (en) Medical devices fabricated from elastomeric alpha-olefins
US5110852A (en) Filament material polylactide mixtures
US4246904A (en) Surgical suture derived from segmented polyether-ester block copolymers
US5554170A (en) Absorbable block copolymers and surgical articles fabricated therefrom

Legal Events

Date Code Title Description
AS Assignment

Owner name: TYCO HEALTHCARE GROUP LP, CONNECTICUT

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KENNEDY, JOHN J.;STOPEK, JOSHUA;ROBY, MARK;SIGNING DATESFROM 20090820 TO 20090924;REEL/FRAME:027625/0900

AS Assignment

Owner name: COVIDIEN LP, MASSACHUSETTS

Free format text: CHANGE OF NAME;ASSIGNOR:TYCO HEALTHCARE GROUP LP;REEL/FRAME:029065/0448

Effective date: 20120928